# Postal Realty Trust, Inc.: financial statements, quarterly

PSTL · NYSE · CIK 1759774 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pstl.md) · [Financials](/companies/pstl/financials.md) · [Filings](/companies/pstl/filings.md) · [Insiders](/companies/pstl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pstl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.1](/filings/0001628280-24-045039.md) | [17.0 d](/filings/0001628280-25-008338.md) | [17.3](/filings/0001628280-25-021292.md) | [18.1](/filings/0001628280-25-037487.md) | [19.7](/filings/0001628280-25-048879.md) | [21.4 d](/filings/0001628280-26-011212.md) | [22.2](/filings/0001628280-26-030708.md) | [23.4](/filings/0001628280-26-052551.md) | [24.3](/filings/0001628280-25-048879.md) | [26.0 d](/filings/0001628280-26-011212.md) | [26.6](/filings/0001628280-26-030708.md) | [28.6](/filings/0001628280-26-052551.md) |
| Operating income | $m | [3.8](/filings/0001628280-24-045039.md) | [4.0 d](/filings/0001628280-25-008338.md) | [3.0](/filings/0001628280-25-021292.md) | [4.1](/filings/0001628280-25-037487.md) | [4.8](/filings/0001628280-25-048879.md) | [9.2 d](/filings/0001628280-26-011212.md) | [6.3](/filings/0001628280-26-030708.md) | [8.7](/filings/0001628280-26-052551.md) | [9.1](/filings/0001628280-25-048879.md) | [10.2 d](/filings/0001628280-26-011212.md) | [9.2](/filings/0001628280-26-030708.md) | [11.3](/filings/0001628280-26-052551.md) |
| Interest expense | $m | [2.4](/filings/0001628280-24-045039.md) | [2.5 d](/filings/0001628280-24-008057.md) | [2.6](/filings/0001628280-24-021182.md) | [2.9](/filings/0001628280-24-035218.md) | [3.2](/filings/0001628280-24-045039.md) | [3.3 d](/filings/0001628280-26-011212.md) | [3.4](/filings/0001628280-26-030708.md) | [3.8](/filings/0001628280-26-052551.md) | [3.9](/filings/0001628280-25-048879.md) | [4.1 d](/filings/0001628280-26-011212.md) | [4.1](/filings/0001628280-26-030708.md) | [4.6](/filings/0001628280-26-052551.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-045039.md) | [0.0 d](/filings/0001628280-25-008338.md) | [0.0](/filings/0001628280-25-021292.md) | [0.0](/filings/0001628280-25-037487.md) | [0.0](/filings/0001628280-25-048879.md) | [0.0 d](/filings/0001628280-26-011212.md) | [0.0](/filings/0001628280-26-030708.md) | [0.0](/filings/0001628280-26-052551.md) | [0.0](/filings/0001628280-25-048879.md) | [(0.0) d](/filings/0001628280-26-011212.md) | [0.0](/filings/0001628280-26-030708.md) | [0.0](/filings/0001628280-26-052551.md) |
| Net income | $m | [1.2](/filings/0001628280-24-045039.md) | [1.2 d](/filings/0001628280-25-008338.md) | [0.2](/filings/0001628280-25-021292.md) | [0.8](/filings/0001628280-25-037487.md) | [1.1](/filings/0001628280-25-048879.md) | [4.5 d](/filings/0001628280-26-011212.md) | [2.1](/filings/0001628280-26-030708.md) | [3.6](/filings/0001628280-26-052551.md) | [3.8](/filings/0001628280-25-048879.md) | [4.6 d](/filings/0001628280-26-011212.md) | [3.8](/filings/0001628280-26-030708.md) | [5.1](/filings/0001628280-26-052551.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001628280-24-045039.md) | not reported | [(0.01)](/filings/0001628280-25-021292.md) | [0.02](/filings/0001628280-25-037487.md) | [0.03](/filings/0001628280-25-048879.md) | not reported | [0.06](/filings/0001628280-26-030708.md) | [0.12](/filings/0001628280-26-052551.md) | [0.13](/filings/0001628280-25-048879.md) | not reported | [0.11](/filings/0001628280-26-030708.md) | [0.15](/filings/0001628280-26-052551.md) |
| Basic EPS | $ per share | [0.04](/filings/0001628280-24-045039.md) | not reported | [(0.01)](/filings/0001628280-25-021292.md) | [0.02](/filings/0001628280-25-037487.md) | [0.03](/filings/0001628280-25-048879.md) | not reported | [0.06](/filings/0001628280-26-030708.md) | [0.12](/filings/0001628280-26-052551.md) | [0.13](/filings/0001628280-25-048879.md) | not reported | [0.11](/filings/0001628280-26-030708.md) | [0.15](/filings/0001628280-26-052551.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.5](/filings/0001628280-23-035502.md) | [2.2](/filings/0001628280-25-008338.md) | [1.9](/filings/0001628280-24-021182.md) | [1.7](/filings/0001628280-24-035218.md) | [1.0](/filings/0001628280-24-045039.md) | [1.8](/filings/0001628280-26-011212.md) | [0.6](/filings/0001628280-25-021292.md) | [1.1](/filings/0001628280-25-037487.md) | [1.9](/filings/0001628280-25-048879.md) | [1.5](/filings/0001628280-26-052551.md) | [1.3](/filings/0001628280-26-030708.md) | [1.8](/filings/0001628280-26-052551.md) |
| Total assets | $m | [554](/filings/0001628280-23-035502.md) | [567](/filings/0001628280-25-008338.md) | [584](/filings/0001628280-24-021182.md) | [608](/filings/0001628280-24-035218.md) | [615](/filings/0001628280-24-045039.md) | [647](/filings/0001628280-26-011212.md) | [654](/filings/0001628280-25-021292.md) | [690](/filings/0001628280-25-037487.md) | [735](/filings/0001628280-25-048879.md) | [759](/filings/0001628280-26-052551.md) | [793](/filings/0001628280-26-030708.md) | [837](/filings/0001628280-26-052551.md) |
| Total liabilities | $m | [254](/filings/0001628280-23-035502.md) | [266](/filings/0001628280-25-008338.md) | [271](/filings/0001628280-24-021182.md) | [299](/filings/0001628280-24-035218.md) | [306](/filings/0001628280-24-045039.md) | [329](/filings/0001628280-26-011212.md) | [339](/filings/0001628280-25-021292.md) | [365](/filings/0001628280-25-037487.md) | [387](/filings/0001628280-25-048879.md) | [399](/filings/0001628280-26-052551.md) | [422](/filings/0001628280-26-030708.md) | [419](/filings/0001628280-26-052551.md) |
| Long-term debt | $m | [232](/filings/0001628280-23-035502.md) | [241](/filings/0001628280-25-008338.md) | [248](/filings/0001628280-24-021182.md) | [274](/filings/0001628280-24-035218.md) | [277](/filings/0001628280-24-045039.md) | [297](/filings/0001628280-26-011212.md) | [307](/filings/0001628280-25-021292.md) | [329](/filings/0001628280-25-037487.md) | [347](/filings/0001628280-25-048879.md) | [361](/filings/0001628280-26-052551.md) | [386](/filings/0001628280-26-030708.md) | [382](/filings/0001628280-26-052551.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [245](/filings/0001628280-23-035502.md) | [244](/filings/0001628280-25-008338.md) | [248](/filings/0001628280-24-021182.md) | [245](/filings/0001628280-24-035218.md) | [246](/filings/0001628280-24-045039.md) | [251](/filings/0001628280-26-011212.md) | [245](/filings/0001628280-25-021292.md) | [251](/filings/0001628280-25-037487.md) | [274](/filings/0001628280-25-048879.md) | [285](/filings/0001628280-26-052551.md) | [292](/filings/0001628280-26-030708.md) | [335](/filings/0001628280-26-052551.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.7 d](/filings/0001628280-24-045039.md) | [7.1 d](/filings/0001628280-25-008338.md) | [6.4](/filings/0001628280-25-021292.md) | [9.9 d](/filings/0001628280-25-037487.md) | [8.0 d](/filings/0001628280-25-048879.md) | [9.2 d](/filings/0001628280-26-011212.md) | [10.8](/filings/0001628280-26-030708.md) | [11.4 d](/filings/0001628280-26-052551.md) | [10.9 d](/filings/0001628280-25-048879.md) | [11.3 d](/filings/0001628280-26-011212.md) | [10.9](/filings/0001628280-26-030708.md) | [14.1 d](/filings/0001628280-26-052551.md) |
| Dividends paid | $m | [6.1 d](/filings/0001628280-24-045039.md) | [6.4 d](/filings/0001628280-25-008338.md) | [6.9](/filings/0001628280-25-021292.md) | [6.9 d](/filings/0001628280-25-037487.md) | [7.0 d](/filings/0001628280-25-048879.md) | [7.2 d](/filings/0001628280-26-011212.md) | [7.4](/filings/0001628280-26-030708.md) | [7.6 d](/filings/0001628280-26-052551.md) | [7.7 d](/filings/0001628280-25-048879.md) | [8.1 d](/filings/0001628280-26-011212.md) | [8.8](/filings/0001628280-26-030708.md) | [8.7 d](/filings/0001628280-26-052551.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.6](/filings/0001628280-23-035502.md) | [19.3](/filings/0001628280-24-021182.md) | [19.5](/filings/0001628280-24-035218.md) | [20.3](/filings/0001628280-24-045039.md) | [22.0](/filings/0001628280-25-021292.md) | [22.3](/filings/0001628280-25-037487.md) | [22.7](/filings/0001628280-25-048879.md) | [23.2](/filings/0001628280-26-030708.md) | [23.5](/filings/0001628280-26-052551.md) | [24.6](/filings/0001628280-25-048879.md) | [27.3](/filings/0001628280-26-030708.md) | [27.7](/filings/0001628280-26-052551.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,248,873 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052551.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.